Discounted Cash Flow (DCF) Analysis Levered
Physicians Realty Trust (DOC)
$12.19
+0.12 (+0.99%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 422.55 | 415.28 | 437.51 | 457.70 | 526.64 | 557.32 | 589.80 | 624.17 | 660.54 | 699.03 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
Operating Cash Flow | 208.69 | 201.18 | 233.30 | 247.56 | 258.40 | 283.47 | 299.98 | 317.46 | 335.96 | 355.54 |
Operating Cash Flow (%) | ||||||||||
Capital Expenditure | -34.64 | -40.14 | -33.89 | -32.57 | -39.87 | -44.91 | -47.53 | -50.30 | -53.23 | -56.33 |
Capital Expenditure (%) | ||||||||||
Free Cash Flow | 174.06 | 161.04 | 199.41 | 214.99 | 218.53 | 238.55 | 252.45 | 267.16 | 282.73 | 299.21 |
Weighted Average Cost Of Capital
Share price | $ 12.19 |
---|---|
Beta | 0.792 |
Diluted Shares Outstanding | 239.61 |
Cost of Debt | |
Tax Rate | 65.65 |
After-tax Cost of Debt | 1.29% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 8.312 |
Total Debt | 1,923.13 |
Total Equity | 2,920.85 |
Total Capital | 4,843.98 |
Debt Weighting | 39.70 |
Equity Weighting | 60.30 |
Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 422.55 | 415.28 | 437.51 | 457.70 | 526.64 | 557.32 | 589.80 | 624.17 | 660.54 | 699.03 |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | 208.69 | 201.18 | 233.30 | 247.56 | 258.40 | 283.47 | 299.98 | 317.46 | 335.96 | 355.54 |
Capital Expenditure | -34.64 | -40.14 | -33.89 | -32.57 | -39.87 | -44.91 | -47.53 | -50.30 | -53.23 | -56.33 |
Free Cash Flow | 174.06 | 161.04 | 199.41 | 214.99 | 218.53 | 238.55 | 252.45 | 267.16 | 282.73 | 299.21 |
WACC | ||||||||||
PV LFCF | 226.07 | 226.73 | 227.39 | 228.05 | 228.72 | |||||
SUM PV LFCF | 1,136.96 |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | 5.52 |
Free cash flow (t + 1) | 305.19 |
Terminal Value | 8,670.18 |
Present Value of Terminal Value | 6,627.57 |
Intrinsic Value
Enterprise Value | 7,764.53 |
---|---|
Net Debt | 1,915.40 |
Equity Value | 5,849.13 |
Shares Outstanding | 239.61 |
Equity Value Per Share | 24.41 |